7 research outputs found
Economic Discrimination; Denial of Social Security Benefits Premised on Gender-Based Classification is Unconstitutional; Violates Equal Protection; Weinberger v. Wiesenfeld
After his wife\u27s death, Wiesenfeld applied for social security survivor benefits for himself and his infant son. While he was able to obtain benefits for his son under 42 U.S.C. Section 402(d), he was denied benefits under Section 402(g) because those benefits were available only to widows and surviving divorced mothers. When his application was denied, Wiesenfeld brought suit in federal district court to obtain declaratory and injunctive relief,\u27 contending that the gender-based classification of 42 U.S.C. Section 402(g) violated equal protection as found within the due process clause of the fifth amendment.\u27 A three-judge district court panel granted relief finding that the different treatment mandated by 42 U.S.C. Section 402(g) unjustifiably discriminated against women wage-earners by affording their survivors less protection than is provided the survivors of male wage-earners
Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients
There is a paucity of data to support evidence-based practices in the provision of patient/family education in the context of a new childhood cancer diagnosis. Since the majority of children with cancer are treated on pediatric oncology clinical trials, lack of effective patient/family education has the potential to negatively affect both patient and clinical trial outcomes. The Children’s Oncology Group Nursing Discipline convened an interprofessional expert panel from within and beyond pediatric oncology to review available and emerging evidence and develop expert consensus recommendations regarding harmonization of patient/family education practices for newly diagnosed pediatric oncology patients across institutions. Five broad principles, with associated recommendations, were identified by the panel, including recognition that (1) in pediatric oncology, patient/family education is family-centered; (2) a diagnosis of childhood cancer is overwhelming and the family needs time to process the diagnosis and develop a plan for managing ongoing life demands before they can successfully learn to care for the child; (3) patient/family education should be an interprofessional endeavor with 3 key areas of focus: (a) diagnosis/treatment, (b) psychosocial coping, and (c) care of the child; (4) patient/family education should occur across the continuum of care; and (5) a supportive environment is necessary to optimize learning. Dissemination and implementation of these recommendations will set the stage for future studies that aim to develop evidence to inform best practices, and ultimately to establish the standard of care for effective patient/family education in pediatric oncology
Indicators of pulmonary exacerbation in cystic fibrosis: A Delphi survey of patients and health professionals
Background: There is uncertainty about the most important indicators of pulmonary exacerbations in CF.
Methods: Two parallel Delphi surveys in 13 CF centres (UK and Ireland). Delphi 1: 31 adults with CF, ≥ one exacerbation over 12 months. Delphi 2: 38 CF health professionals. Rounds 1 and 2 participants rated their level of agreement with statements relating to indicators of exacerbation; Round 3 participants rated the importance of statements which were subsequently placed in rank order.
Results: Objective measurements were of higher importance to health professionals. Feelings of increased debility were rated most important by adults with CF.
Conclusions: There were clear differences in perspectives between the two groups as to the most important indicators of an exacerbation. This highlights that CF health professionals should take more cognisance of specific signs and symptoms reported by adults with CF, especially since these may be a precursor to an exacerbation
Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients: Consensus Recommendations from a Children’s Oncology Group Expert Panel
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Infectious and inflammatory diseases have repeatedly shown strong genetic associations within the major histocompatibility complex (MHC); however, the basis for these associations remains elusive. To define host genetic effects on the outcome of a chronic viral infection, we performed genome-wide association analysis in a multiethnic cohort of HIV-1 controllers and progressors, and we analyzed the effects of individual amino acids within the classical human leukocyte antigen (HLA) proteins. We identified >300 genome-wide significant single-nucleotide polymorphisms (SNPs) within the MHC and none elsewhere. Specific amino acids in the HLA-B peptide binding groove, as well as an independent HLA-C effect, explain the SNP associations and reconcile both protective and risk HLA alleles. These results implicate the nature of the HLA-viral peptide interaction as the major factor modulating durable control of HIV infection